Filing Flows › Connect Biopharma Holdings (CNTB) › Q2 2026 › vs Q2 2025
Connect Biopharma Holdings (CNTB) Q2 2026 vs Q2 2025 (year over year)
Connect Biopharma Holdings's revenue rose $2.7M (58×) from $48K in Q2 2025 to $2.8M in Q2 2026.
Connect Biopharma Holdings, Q2 2026: revenue $2.8M (58× year over year), operating margin -636.0%, net loss $17.3M, operating cash flow −$15.9M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.8M | $48K | $2.7M | 58× |
| Other income, net | $380K | $580K | −$200K | -34% |
| Net loss | $17.3M | $12.9M | $4.4M | +34% |
| Costs & expenses | $20.4M | $13.5M | $6.9M | +51% |
| Operating costs | $20.4M | $13.5M | $6.9M | +51% |
| Income tax | $60K | $55K | $5K | +9% |
| Research & development | $16.3M | $8.8M | $7.5M | +85% |
| General & admin | $4.1M | $4.7M | −$600K | -13% |
| Operating cash sources | $17.3M | $13.7M | $3.6M | +26% |
| Depreciation & amortization | $161K | $171K | −$10K | -6% |
| Share-based compensation | $1.3M | $951K | $310K | +33% |
| Cash used in operations | $15.9M | $12.6M | $3.3M | +26% |
| Net loss absorbed | $17.3M | $12.9M | $4.4M | +34% |
| Working capital & other | $60K | $814K | −$754K | -93% |
Questions
How much did Connect Biopharma Holdings's revenue grow year over year in Q2 2026?
Connect Biopharma Holdings's revenue rose $2.7M (58×) from $48K in Q2 2025 to $2.8M in Q2 2026.